A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors	Advanced/Metastatic Solid Tumors	Recruiting	Phase 1	2026-04-15		NCT05718895

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Antengene Biologics Limited	4

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	34
Beijing Gobroad Hospital	Beijing	China	10
Cabrini Health Limited	Malvern	Australia	1
Cancer Research SA Pty Ltd	Adelaide	Australia	1
Fudan University Shanghai Cancer Center	Shanghai	China	128
Fujian Cancer Hospital	Fuzhou	China	37
Gansu provincial cancer hospital [recruiting]	Lanzhou	China	1
General Hospital of Ningxia Medical University	Yinchuan	China	17
Hubei Cancer Hospital	Wuhan	China	23
Integrated Clinical Oncology Network Pty Ltd (Icon)	South Brisbane	Australia	1
Jinan Central Hospital	Jinan	China	15
Liaoning Cancer Hospital	Shenyang	China	14
Shanxi Provincial Cancer Hospital	Taiyuan	China	16
The Affiliated Hospital of Qingdao University	Qingdao	China	22
The First Affiliated Hospital of Anhui Medical University	Hefei	China	28
The First affiliated hospital of Xi'An Jiao Tong Ubiversity	Xi'an	China	1
The First Affiliated Hospital of Zhenghzou University	Zhengzhou	China	1
The Fourth Hospital of Hebei Medical University	Shijiangzhuang	China	1
Tianjin Medical Universuty Cancer Institute & Hospital	Tianjin	China	1
Tongren Hospital Shanghai	Shanghai	China	1
West China Hospital, Sichuan University	Chengdu	China	30
Xuzhou Central Hospital	Xuzhou	China	16

Clinical trials